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We have studied the role of prostaglandin E on the modulation of tumor 
necrosis factor by immunologically elicited an 8 lipopolysaccharide treated 
murine macrophages. Indomethacin, a potent inhibitor of prostaglandin E 
production, caused a dose dependent augmentation of-jipopolysaccharide induce i; 
tumor necrosis factor production (2-3 fold at 10 molar). Tumor necrosis 
factor was released into the extracellular environment and no activity was 
found to be associated with membrane or cytosolic fractions. Prostaglandin E 
added to the lipopolysaccharide treated cultures supprgfsed tumor necrosl 4 
factor in a dose dependent manner. In these studies, 10 molar PGE 
tumor necrosis factor production to basal levels. These data suggest 
may be a potent autoregulatory factor that dramatically influences turn0 
necrosis factor production. @ 1986 Academic Press. Inc. 
Macrophage-derived tumor necrosis factor (TNF)** is being increasingly 
recognized as an important monokine effecting a variety of target cells in 
diverse ways. Although tumor cells were the original targets as defined by 
Carswell et al. (l), it is no longer accurate to regard TNF solely as an 
oncolytic agent. Current evidence demonstrates that TNF may stimulate a 
variety of cellular responses. For example, TNF has been identified as a 
macrophage product that: a) binds to high affinity receptors present on 
adipocytes (2) and suppresses the production of lipoprotein lipase (2,3), b) 
enhances neutrophil-mediated antibody dependent cytotoxicity (4), c) augments 
polymorphonuclear neutrophil phagocytosis (4) and, d) modulates the prolifer- 
ation of numerous human and murine cell lines (5). 
While it is known that macrophages and macrophage cell lines can elaborate 
TNF in response to endotoxin and other bacterial or protozoa1 products (6), 
**Abbreviations used in this paper: 
TNF, tumor necrosis factor; LPS, lipopolysaccharide, CO, cyclooxygenase; 
CFA, complete Freund's adjuvant. 
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there is little information regarding factors that modulate TNF production. 
Considering the pleomorphic effects of TNF on various physiologic and immuno- 
logic activities, information regarding the modulation of TNF production may 
aid the understanding of both physiologic homeostatic and immune processes. 
In this paper, we demonstrate that lipopolysaccharide (LPS) induced TNF 
production by activated murine macrophages is suppressed by low molar concen- 
trations of exogenous prostaglandin E2 (PGE2), while LPS-induced TNF production 
is augmented by the cyclooxygenase (CO) inhibitor indomethacin. Furthermore, 
the production of TNF by immunologically activated macrophages is refractory to 
the phagocytic challenge zymosan either in the presence or absence of indo- 
methacin. We provide evidence for a murine model of TNF production that 
demonstrates stimulus specificity and appears to be 
control of PGE2. 
MATERIALS AND METHODS 
Animals - Female, specific pathogen-free CBA/J mice 
Bar Harbor, ME) were used in cell experiments. Mice 
under the regulatory 
(Jackson Laboratories, 
were maintained under 
pathogen-free conditions and given food and water ad libitum. 
Macrophage cultures - Resident peritoneal macrophages were recovered from 
normal mice by repeated washing of the peritoneal cavity (10 x 1 ml of RPMI- 
1640 culture medija). This macrophage population was washed 3x and then su- 
spended to 1 x 10 MB/ml RPM1 with 5% fetal bovine serum (FBS) containing 100 U 
penicillin and 100 ug streptomycin/ml. One ml of suspension was placed onto 35 
mm sterile plastic culture dishes. After 2h incubation (37'C, 5% CO,,, 100% 
humidity), non-adherent cells were removed by two vigorous rinses. Elicited 
peritoneal macrophages were recruited using either light mineral oil, thio- 
glycollate, or complete Freunds adjuvant (CFA) as follows: 2 mls of either 
Marco?-52 mineral oil or thioglycollate or 0.5 mls of CFA (CFA diluted 1:l with 
sterile saline) were asceptically administered via an intraperitoneal injec- 
tion, four days post oil or thioglycollate or 14 days post CFA administration 
the macrophages were harvested by repeating washing of the peritoneal cavity, 
the cells were then washed and resuspended in complete culture media, and 
plated as described in the above methods for the resident macrophages. 
After the initial 2h adherence period, the monolayers were overlaid with 1 
ml of serum-free media containing antibiotics plus the stimulus being tested 
for TNF induction, zymosan (250 pg/ml) or E. coli LPS (Sigma Chemical Co., St. 
Louis, MO). 
-- 
Cell-free supernates were collected after 16h incubation. The 
total number of macrophages was quantitated by scraping the cells from the 
culture dishes and counting in a hemacytometer. All macrophage populations 
were >95% mononuclear phagocytes as determined by staining, morphologic, and 
phagocytic indices. 
Arachidonate metabolites and inhibitors - Prostaglandin E 
2 
was kindly 
provided by the Upjohn Co. (Kalamazoo, MI). Purity of the pros aglandins was 
confirmed by high pressure liquid chromatography as previously described (7). 
The in vitro specificity of indomethacin (Sigma Chemical Co.), as an inhibitor -- 
of products derived from the CO pathway, was assessed as previously published 
(8). . _ 
Radioimmunoassays for arachidonate metabolites - Cell-free culture medium 
from the various macrophage populations was subject to radioimmunoassay for 
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PGE 
4 
(New England Nuclear, Boston, MA). Bound and free ligand were separated 
us1 g dextran-coated charcoal. Sensitivity for PGE was 8 picograms. 
Tumor necrosis factor assay - The activity o 3 TNF was monitored using a 
semi-automated L929 fibrob4ast lytic assay as previously described (9). 
Briefly, L929 cells (5 x 10 /O.l ml) in the presence of 1 pg/ml actinomycin D 
were cultured with serial 1:2 dilutions of test samples in 96-well, flat bottom 
microtiter plates (Costar, Cambridge, MA) at 37'C, 5% CO /95% air humidified 
incubator. After 18h incubation the plates were washed an ci! the remaining cells 
stained with crystal violet (0.5%) in methanol/water (1:4, V/V). The amount of 
cell lysis was determined using a micro ELISA autoreader. Units of TNF activi- 
ty was defined as the reciprocal of the dilution necessary to lyse 50% of the 
L929 target cells. An internal standard of TNF was included in each assay; 
this material was a gift from Dr. Leo Lin; Cetus Corp., Emeryville, CA. 
Statistical analysis - The Student's t-test was used to compare control 
and experimental groups. Values of p > -05 was considered not significant. 
RESULTS 
Production of TNF by various elicited and resident murine macrophage 
populations. Numerous studies have demonstrated that resting and elicited 
murine macrophage populations possess diverse morphologic and functional 
characteristics (10). This diversity is also reflected in the spectrum of 
inflammatory mediators produced by macrophages. As shown in Figure 1, TNF 
0 .Ol .l 1 10 
LPS fugI 
Figure 1. Production of tumor necrosis factor in response to graded doses 
of LPS. Only those immunologically activated macrophages responded 
with a significant production of TRF in response to LPS. As a 
control, all TRF activity was destroyed by heating samples to 6O'C 
for 30 min. CFA, complete Fraund's adjuvant elicited; THIO, thio- 
glycollate elicited; OIL, oil elicited, and RES, resident macro- 
phages. Data represents mean + SRM of triplicates from three 
separate experiments. 
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production varied dramatically depending upon both the concentration of the LPS 
stimulus and the macrophage population under study. Complete Freund's adjuvant 
(CFA) elicited macrophages demonstrated augmented TNF production that was 
dependent upon the dose of LPS. TNF production by CFA elicited macrophages was 
first apparent between lo-100 rig/ml LPS and increased in a linear fashion up to 
10 ug/ml. The only other macrophage population that demonstrated a significant 
capacity to produce TNF was thioglycollate elicited macrophages and then only 
when incubated with high levels of LPS (10 ug/ml). Resident and oil elicited 
peritoneal macrophages did not produce significant TNF even when incubated with 
10 rig/ml LPS. While LPS proved to be a potent soluble stimulus for the pro- 
duction of TNF by CFA elicited macrophages, the phagocytic stimulus zymosan 
(250 ug/ml) did not induce the production of TNF by any of the resident or 
elicited macrophage populations. In addition, TNF activity was not found to be 
cell-associated in any of the above macrophage populations. Neither cytosolic 
nor membrane samples prepared by ultracentrifugation (100,OOOxg for 20 min) of 
freeze-thawed or sonicated macrophages demonstrated TNF activity. 
Effect of the cyclooxygenase inhibitor indomethacin on LPS-induced tumor 
necrosis factor production. Having defined CFA elicited macrophages as a 
significant cellular source of TNF, we utilized this macrophage population to 
study the potential regulatory effect of prostaglandins. Using the cyclo- 
oxygenase inhibitor, indomethacin, a dose dependent augmentation of TNF 
production was found which reached a maximum at 10-7M (Figure 2). At this 
concentration of indomethacin, LPS induced-TNF production was augmented 2-3 
fold. Indomethacin had no augmenting effect on the production of TNF by 
zymosan treated CFA macrophages. Indomethacin alone had no effect on macro- 
phage TNF production in the absence of LPS stimulation nor altered the 
viability of the L929 cells at any of the concentrations under study. Figure 2 
also shows the dose dependent suppression of LPS-induced PGE2 production by 
indomethacin. An inverse relationship appears to exist between PGE2 and TNF 
production. Thus, this provided strong circumstantial evidence that PGE2 
suppressed TNF production. 
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Figure 2. Effect of the cyclooxygenase inhibitor indomethacin on LPS 
induced TNF and PGE2 production by CFA elicited macrophages. Indo- 
methacin induced a dose dependent reduction in PGE2 levels with a 









CFA + 10 ug LPS . . 
elicited macrophages. Indomethacin alone had no effect on the lytic 
assay. Data represents mean + SEM of triplicates from three separate 
experiments. 
Figure 3. Effect of exogenous PGE2 on LPS (10 ug/ml)-induced TNF 
production. Complete Freund’s adjuvant-elicited macrophages were 
stimulated 16 hours with LPS in the presence of graded concentrations 
of PGE 
2’ 
then supernates were tested for TNF activity. PGE2 alone 
had no effect on the lytic assay. Data represents mean f SEM of 
triplicates from three separate experiments. 
Effect of exogenous PGE, on tumor necrosis factor production. The sup- 
pressive effect of PGE2 was confirmed by directly adding this agent to LPS- 
stimulated CFA macrophages. As shown in Figure 3, exogenous PGE2 caused a dose 
dependent suppression of TNF production. At 10m8#, the production of TNF was 
reduced by approximately 90%, while higher concentrations suppressed TNF 
production to basal levels. In control studies, PGE2 alone had no effect on 
the viability of the L929 cells. Thus, PGE2 at low molar concentrations 
appears to directly suppress TNF production. 
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DISCUSSION 
Recent evidence suggests that TNF has a profound influence on cells that 
participate in various facets of the immune response. One of the major cell- 
ular sources for the production of TNF during an immune response appears to be 
macrophages; more specifically, those "activated" macrophages that have inter- 
acted with T-lymphocytes or their products and then triggered with a specific 
agonist (6,ll). In the present report we have utilized LPS treated, immunolo- 
gically elicited mouse peritoneal macrophages as a model to study the regula- 
tory effects of PGE2 on TNF production. We provide evidence that PGE2 can 
down-regulate LPS-induced TNF production at near physiologic concentrations, 
while indomethacin, a potent inhibitor of PGE2 production, has a significant 
augmenting effect. 
Our data imply that TNF production may be endogenously regulated by PGE2, 
potentially in a feedback type manner. This hypothesis is especially intrigu- 
ing since LPS can serve as a stimulus for both TNF and PGE2 production by 
immunologically activated macrophage. Thus, CFA elicited macrophages when 
presented with an LPS challenge not only produce a biologically important 
mediator, TNF, but also produces a signal that may ultimately regulate mediator 
production. It is not clear as yet if TNF plays a role in the induction of 
PGE2 synthesis by macrophages, although a recent study has demonstrated that 
recombinant TNF can stimulate PGEE production by resting macrophages (12). The 
autoregulatory effect of PGE2 on TNF production is supported by the findings 
that gamma interferon which decreases PGE2 production (13) augments lectin- 
induced monocyte TNF production by 5-7 fold (14). 
These data are in accord with recent studies from our laboratory demon- 
strating the ability of PGE2 to act in a classical feedback manner to regulate 
the production of the monokine interleukin-1 (15). In these studies, inter- 
leukin-1 demonstrated characteristics of a classical hormone by inducing the 
production of its own inhibitor. 
In conclusion, we provide evidence that TNF production by LPS-stimulated, 
immunologically-activated macrophages is regulated by PGE2. These studies also 
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lend additional support to the notion that PGE2 is a major autokine determining 
macrophage responsiveness. 
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